Vertex Pharmaceuticals

+$9.05 (+3.19%) Today
$0.00 (0.00%) As of 10:50 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VRTX and other ETFs, options, and stocks.

About VRTX

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis.

CEO
Reshma Kewalramani
Employees
3,900
Headquarters
Boston, Massachusetts
Founded
1989

VRTX Key Statistics

Market cap
74.82B
Price-Earnings ratio
30.83
Dividend yield
—
Average volume
1.96M
High today
$293.09
Low today
$280.40
Open price
$285.01
Volume
4.25M
52 Week high
$293.17
52 Week low
$176.36

VRTX News

Simply Wall St24m

An Intrinsic Calculation For Vertex Pharmaceuticals Incorporated Suggests It's 44% Undervalued

How far off is Vertex Pharmaceuticals Incorporated ( ) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is

VRTX Earnings

$0.00
$1.19
$2.37
$3.56
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Jul 28, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure